Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
19m agoSunrun Prices $584 million Securitization of Residential Solar and Storage Assets
19m agoMadison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
43m agoUltra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
43m agoGridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
43m agoRush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend
Fresenius Se & Co. Kgaa logo

Fresenius Se & Co. Kgaa

About

Fresenius Se & Co. Kgaa (XETRA:FRE) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 9 2026
CMS Grants Fresenius Kabi COVID-19 Indication-Specific HCPCS Codes for Tyenne® (tocilizumab-aazg)
Jan 14 2026
Fresenius Kabi, TQ Therapeutics Announce Cell Therapy Technology Agreement
Dec 18 2025
Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature
Dec 4 2025
mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development
Nov 12 2025
Fresenius Kabi’s Adaptive Nomogram used on Aurora Xi Plasmapheresis System Now Operating Nationwide at BioLife Plasma Centers

Financials

Revenue
€22.87 B
Market Cap
€24.55 B
P/E Ratio
16.02
EPS
2.72
Dividend Yield
2.39%

Community Chat

Ask AI

6ix6ixAIEvents